Coya Therapeutics, Inc.
COYA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,116 | -$6,095 | -$7,307 | -$2,916 |
| Dep. & Amort. | $7 | $7 | $7 | $7 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $1,080,082 | $0 |
| Change in WC | -$609 | -$721 | $3,392 | -$291 |
| Other Non-Cash | $1,587 | $1,036 | -$3,904,448 | $791 |
| Operating Cash Flow | -$1,131 | -$5,773 | -$2,828,275 | -$2,410 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$516 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$516 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $19 | $0 | $19 | $9,681 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $19,118 | $11 |
| Financing Cash Flow | $19 | $0 | $19,137 | $9,692 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,627 | -$5,773 | -$2,809,138 | $7,282 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $29,757 | $35,531 | $38,339,762 | $31,057 |
| End Cash | $28,130 | $29,757 | $35,530,624 | $38,340 |
| Free Cash Flow | -$1,131 | -$5,773 | -$2,828,275 | -$2,410 |